NEO PROMETHEUS PROTOCOL
SCROLL TO EXPAND
NovaGen and Veea have signed a term sheet for a proposed combination, bringing cellular science and edge AI together in a planned global health platform.
Read on Yahoo Finance (opens in a new tab)The proposed combination remains subject to definitive agreements and closing conditions.
Explore our scienceNovaGen Group is building a research-led platform across cellular science, AI health intelligence, and partner-network education.
We focus on educational information, investigational research context, and tools that support qualified clinical discussion.
Learn MoreCertified Excellence
Our investigational research program combines cellular science, structured laboratory workflows, and partner-network education.
Explore how cellular aging markers are studied through the investigational Neo Prometheus Protocol.
Review cellular and molecular markers as educational inputs for qualified clinical discussion.
From information request to partner-clinic review, the workflow is designed for structured evaluation.
Information request
Questions and research context
Clinical discussion
Independent professional guidance
Partner review
Local requirements and next steps
Educational research across cellular health, tissue biology, immune signaling, metabolism, and healthspan science.
The Journey to Renewal
Six stages of an investigational workflow, guided by clinical partners.
A licensed provider reviews whether any sample collection is appropriate and permitted.
Cellular material may be isolated and expanded through controlled laboratory workflows.
The investigational protocol studies changes in cellular aging markers.
Analytical review may include molecular and cellular marker assessment.
Any clinical use is determined by independent licensed providers under applicable rules.
Follow-up information is reviewed as observational data and educational context.
Learn how the investigational workflow is structured for review by qualified clinical partners.
Discuss the processThe science behind Neo Prometheus
Built on ongoing translational research across cellular biology, epigenetics, metabolism, and immunology.
Research focus
Senescent cells
DNA methylation
Cellular energy
Immune signaling
Senescent cells accumulate with age and are one area of active longevity research. NovaGen Group studies how cellular programs may be characterized and monitored.
DNA methylation patterns are one way researchers study cellular aging. Neo Prometheus Protocol explores epigenetic reprogramming concepts without DNA editing.
Mitochondrial function changes with age. Research workflows monitor energy-related markers alongside other cellular signals.
Immune signaling is part of the broader cellular aging landscape and remains an important area for preclinical and translational research.
Antibes, France
Clinique DelMar
Clinical partnerships
NovaGen Group works with selected partner environments for educational access, clinical discussion, and research-context review where permitted.
Clinical discussion and research-context access at Clinique DelMar are led by qualified providers where permitted.
Planned partnerships
NovaGen Group is evaluating additional partner relationships in selected jurisdictions. Availability depends on local governance and provider review.
Our Team
Led by experienced executives and guided by distinguished advisors
Operators, scientists, and builders coordinating NovaGen Group's research-led platform.
7 leaders
Diederik van der Reijt is the CEO and Co-founder. A serial biotech entrepreneur and investor, he previously built a successful high-frequency trading firm and co-founded NKore Biotherapeutics, and now leverages his finance and venture capital background to democratize access to breakthrough cellular therapies.
Chief Scientific Officer
Professor, UCLA Department of Molecular & Medical Pharmacology. Pioneer in neural stem cell biology and leading expert in cellular reprogramming. Academic excellence with breakthrough discoveries in JAK-STAT pathways and successful translation from bench to bedside.
Co-founded and led more than 20 life sciences companies, including Drug Discovery Factory, Skyline Diagnostics, Julius Clinical, DC4U, MyLife Technologies, and Oncodrone. Physician, scientist, and serial biotech entrepreneur with expertise in clinical immunology, transfusion medicine, and genetics.
He is a member of the OECD's AI Expert Group and CEO of Erasmus.AI, a platform creating domain-specific AI models like ClimateGPT, the world's first foundational Climate Change model. With 25 years of experience in strategy and foresight advisory, he is also a full member of the Club of Rome.
Scientific and clinical advisors supporting research context and review.
5 members
Member of the European Board of Plastic Surgeons (EBOPRAS), specializes in Plastic, Reconstructive, and Aesthetic Surgery. President of the French Society of Aesthetic Plastic Surgery (SOFCEP) and member of IPRAS and ESPRAS.
Cardiologist & Functional Medicine Doctor
Cardiologist, morphologist, and anti-aging physician with training in nutritional and functional medicine with Professor Vincent Castronovo. President of AEM2F, the European Association of Mitronutrition and Functional Medicine.
Orthopedic surgeon at ACIBADEM International Medical Center with expertise in hip, knee, and ankle conditions, including sports orthopedics and arthroscopic treatment of ankle and knee injuries. He trained in medicine and orthopedics in Amsterdam and completed a PhD on evidence-based diagnosis and treatment of acute ankle injuries.
Founder and Medical Director of Body & Soul in Shanghai. With over 20 years' experience in Traditional Chinese and Western Medicine, specializes in women's health, fertility, and pediatrics, delivering care in four languages.
Biomedical engineer and translational scientist focused on turning frontier longevity and regenerative medicine research into deployable therapies. Leads NovaGen Group's innovation pipeline, bridging AI-driven discovery, clinical partners, and global research networks.
Global advisors across finance, partnerships, governance, and cross-border strategy.
7 members
Global business leader with 40+ years experience specializing in cross-border investments in Asia and the Middle East. Founder of the George H. W. Bush Foundation for U.S.-China Relations. Chairs Points of Light and the Bush School Advisory Board.
Entrepreneur and strategic investor with a background in technology, internet, media, and health ventures. She founded multiple companies, later invested across media and internet companies, and is now involved with NovaGen’s regenerative longevity platform.
International technology executive with more than 20 years of leadership experience across AI, software, IT, and telecommunications. He has held senior roles at NVIDIA, Colt Technology Services, ACN, Active 24, Versatel, KPN, and British Telecom, with a focus on scaling regional growth and AI adoption.
Capital Market Advisor
Is a global senior advisor, executive and investor with extensive experience in international corporate development, M&A, board management, capital markets and communications across technology, AI, software, media, blockchain and growth industries.
Advisor
Former British Consul-General to Hong Kong, graduated from Oxford in 1980 and studied at Fudan University. Leverages extensive diplomatic experience across Asia to advise on cross-border consultancy and strategic development. Serves on the boards of Cenovus Energy Inc., CK Asset Holdings, and Power Assets Holdings.
International business development executive with extensive experience in Asia-Pacific markets and cross-border partnerships. Specializes in strategic planning and market expansion for biotechnology companies, with deep expertise in regulatory affairs and commercial strategy.
Co-founder and Managing Partner of GCW Global Customised Wealth, specializing in private equity and family office investments. Previously held senior positions at Jasper Ridge Partners, Nomura, and Lehman Brothers. Has served as an economic advisor to two U.S. Presidents. Ph.D. in Economics from Stanford University.
Questions & Answers
Research, clinical review, and what happens next.
Can't find what you're looking for? Contact our specialist team
Your next step
Curious about Neo Prometheus? Get in touch to learn more about our research and partner network.
Request informationImportant Medical Notice: Content on this website is educational and informational only. NovaGen Group does not provide medical advice, diagnosis, or treatment through this website. Any investigational protocol information should be discussed with qualified, licensed healthcare professionals. Availability and regulatory status vary by jurisdiction.
